Authors : Huang W; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.; Paul D

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/genetics ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy ; Leukemia*/Leukemia*/Leukemia*/genetics

Source: Cells [Cells] 2023 Dec 30; Vol. 13 (1). Date of Electronic Publication: 2023 Dec 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium: Internet ISSN: 2073-4409

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Interplay between proteasome inhibitors and NF-κB pathway in leukemia and lymphoma: a comprehensive review on challenges ahead of proteasome inhibitors.

Authors : Pakjoo M; Department of Hematology, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.; ATMP department, Breast cancer research center, Motamed cancer institute, ACECR, P.O. BOX:15179/64311, Tehran, Iran.

Subjects: Leukemia*/Leukemia*/Leukemia*/drug therapy ; Lymphoma*/Lymphoma*/Lymphoma*/drug therapy ; Hematologic Neoplasms*

Source: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Feb 08; Vol. 22 (1), pp. 105. Date of Electronic Publication: 2024 Feb 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Exploring Thiazolopyridine AV25R: Unraveling of Biological Activities, Selective Anti-Cancer Properties and In Silico Target and Binding Prediction in Hematological Neoplasms.

Authors : Ladwig A; Department of Medicine, Clinic III-Hematology, Oncology and Palliative Care, Rostock University Medical Center, 18057 Rostock, Germany.; Gupta S

Subjects: Hematologic Neoplasms* ; Leukemia*/Leukemia*/Leukemia*/drug therapy ; Antineoplastic Agents*/Antineoplastic Agents*/Antineoplastic Agents*/chemistry

Source: Molecules (Basel, Switzerland) [Molecules] 2023 Dec 15; Vol. 28 (24). Date of Electronic Publication: 2023 Dec 15.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium: Internet ISSN: 1420-3049

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Wilms' tumor gene 1 in hematological malignancies: friend or foe?

Authors : Wu J; Department of Emergency Medicine, The Fifth People's Hospital of Huai'an and Huai'an Hospital Affiliated to Yangzhou University, Huai'an, People's Republic of China.; Yan H

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/genetics ; Leukemia* ; Myelodysplastic Syndromes*

Source: Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2254557.Publisher: Taylor & Francis Country of Publication: England NLM ID: 9708388 Publication Model: Print Cited Medium: Internet ISSN: 1607-8454

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Role of SIRT1 in Chemoresistant Leukemia.

Authors : Fajardo-Orduña GR; Hematopoiesis and Leukemia Laboratory, Research Unit on Cell Differentiation and Cancer, Faculty of High Studies Zaragoza, National Autonomous University of Mexico, Mexico City 09230, Mexico.; Ledesma-Martínez E

Subjects: Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/Drug Resistance, Neoplasm*/genetics ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/genetics ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/therapy

Source: International journal of molecular sciences [Int J Mol Sci] 2023 Sep 23; Vol. 24 (19). Date of Electronic Publication: 2023 Sep 23.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Morphological diagnosis of hematologic malignancy using feature fusion-based deep convolutional neural network.

Authors : Yadav DP; Department of Computer Engineering and Applications, G.L.A. University, Mathura, 281406, India.; Kumar D

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/diagnostic imaging ; Leukemia*/Leukemia*/Leukemia*/diagnostic imaging; Humans

Source: Scientific reports [Sci Rep] 2023 Oct 09; Vol. 13 (1), pp. 16988. Date of Electronic Publication: 2023 Oct 09.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Serum levels of vault RNA significantly varied in patients with haematological malignancies.

Authors : Kato H; Department of Pathobiological Science and Technology, School of Health Science, Tottori University Faculty of Medicine, Yonago, Tottori 683‑8503, Japan.; Hashimoto Y

Subjects: Hematologic Neoplasms* ; MicroRNAs* ; Leukemia*

Source: Molecular medicine reports [Mol Med Rep] 2023 Oct; Vol. 28 (4). Date of Electronic Publication: 2023 Sep 01.Publisher: D. A. Spandidos Country of Publication: Greece NLM ID: 101475259 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Clinical and microbiological profiles in post-chemotherapy neutropenic fever in hematological malignancy: exploration of clinical phenotype patterns by two-step cluster analysis.

Authors : Chan CW; School of Nursing, The Hong Kong Polytechnic University, Hong Kong, Hong Kong, Special Administrative Region of China. .; Molassiotis A

Subjects: Neutropenia*/Neutropenia*/Neutropenia*/microbiology ; Bacterial Infections*/Bacterial Infections*/Bacterial Infections*/drug therapy ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/complications

Source: BMC infectious diseases [BMC Infect Dis] 2023 Apr 13; Vol. 23 (1), pp. 226. Date of Electronic Publication: 2023 Apr 13.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Assessing patient attitudes toward genetic testing for hereditary hematologic malignancy.

Authors : Johnson AQ; The University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, Texas, USA.; Bannon SA

Subjects: Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/diagnosis ; Hematologic Neoplasms*/Hematologic Neoplasms*/Hematologic Neoplasms*/genetics ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/diagnosis

Source: European journal of haematology [Eur J Haematol] 2023 Jan; Vol. 110 (1), pp. 109-116. Date of Electronic Publication: 2022 Oct 21.Publisher: Blackwell Country of Publication: England NLM ID: 8703985 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1600-0609

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي

Academic Journal

Targeting DNA Methylation in Leukemia, Myelodysplastic Syndrome, and Lymphoma: A Potential Diagnostic, Prognostic, and Therapeutic Tool.

Authors : Kalinkova L; Department of Genetics, Cancer Research Institute, Biomedical Research Center of Slovak Academy of Sciences, 845 05 Bratislava, Slovakia.; Sevcikova A

Subjects: Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/diagnosis ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/drug therapy ; Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/Myelodysplastic Syndromes*/genetics

Source: International journal of molecular sciences [Int J Mol Sci] 2022 Dec 30; Vol. 24 (1). Date of Electronic Publication: 2022 Dec 30.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي